These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30418983)

  • 1. The estimated cost of dementia in Japan, the most aged society in the world.
    Sado M; Ninomiya A; Shikimoto R; Ikeda B; Baba T; Yoshimura K; Mimura M
    PLoS One; 2018; 13(11):e0206508. PubMed ID: 30418983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive cost of illness of dementia in Japan: a time trend analysis based on Japanese official statistics.
    Hanaoka S; Matsumoto K; Kitazawa T; Fujita S; Seto K; Hasegawa T
    Int J Qual Health Care; 2019 Apr; 31(3):231-237. PubMed ID: 30272131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Burden of Alzheimer's Disease Dementia in Japan.
    Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K
    J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method.
    Hirata K; Matsumoto K; Hatakeyama Y; Onishi R; Seto K; Hasegawa T
    PLoS One; 2023; 18(1):e0280311. PubMed ID: 36630469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The economic and social burden of dementia diseases in Germany-A meta-analysis].
    Michalowsky B; Kaczynski A; Hoffmann W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Aug; 62(8):981-992. PubMed ID: 31297549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
    Wimo A; Jönsson L; Fratiglioni L; Sandman PO; Gustavsson A; Sköldunger A; Johansson L
    Alzheimers Res Ther; 2016 Nov; 8(1):59. PubMed ID: 27986093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The worldwide societal costs of dementia: Estimates for 2009.
    Wimo A; Winblad B; Jönsson L
    Alzheimers Dement; 2010 Mar; 6(2):98-103. PubMed ID: 20298969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of schizophrenia in Japan.
    Sado M; Inagaki A; Koreki A; Knapp M; Kissane LA; Mimura M; Yoshimura K
    Neuropsychiatr Dis Treat; 2013; 9():787-98. PubMed ID: 23785238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal Costs of Dementia: 204 Countries, 2000-2019.
    Lastuka A; Bliss E; Breshock MR; Iannucci VC; Sogge W; Taylor KV; Pedroza P; Dieleman JL
    J Alzheimers Dis; 2024; 101(1):277-292. PubMed ID: 39150827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach.
    Sado M; Takechi S; Inagaki A; Fujisawa D; Koreki A; Mimura M; Yoshimura K
    BMC Psychiatry; 2013 Dec; 13():338. PubMed ID: 24350841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of dementia in Switzerland.
    Kraft E; Marti M; Werner S; Sommer H
    Swiss Med Wkly; 2010; 140():w13093. PubMed ID: 22250014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of delirium in Australia: a cost of illness study.
    Pezzullo L; Streatfeild J; Hickson J; Teodorczuk A; Agar MR; Caplan GA
    BMJ Open; 2019 Sep; 9(9):e027514. PubMed ID: 31530588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who pays and who benefits? How different models of shared responsibilities between formal and informal carers influence projections of costs of dementia management.
    Vickland V; Werner J; Morris T; McDonnell G; Draper B; Low LF; Brodaty H
    BMC Public Health; 2011 Oct; 11():793. PubMed ID: 21988908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projections of Socioeconomic Costs for Individuals with Dementia in China 2020-2050: Modeling Study.
    Wu Y; Liu Y; Liu Y; Chen Y; Lobanov-Rostovsky S; Zhang Y; Liu Y; Brunner EJ; French E; Liao J
    J Alzheimers Dis; 2024; 101(4):1321-1331. PubMed ID: 39302371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations.
    Goto R; Uda A; Hiroi S; Iwasaki K; Takashima K; Oya M
    J Med Econ; 2017 Nov; 20(11):1155-1162. PubMed ID: 28758810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The main cost drivers in dementia: a systematic review.
    Schaller S; Mauskopf J; Kriza C; Wahlster P; Kolominsky-Rabas PL
    Int J Geriatr Psychiatry; 2015 Feb; 30(2):111-29. PubMed ID: 25320002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic costs of dementia in Korea, 2002.
    Suh GH; Knapp M; Kang CJ
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):722-8. PubMed ID: 16858741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs in primary care patients with dementia: baseline results of the DelpHi-trial.
    Michalowsky B; Flessa S; Eichler T; Hertel J; Dreier A; Zwingmann I; Wucherer D; Rau H; Thyrian JR; Hoffmann W
    Eur J Health Econ; 2018 Jan; 19(1):87-102. PubMed ID: 28160100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of dementia in England.
    Wittenberg R; Knapp M; Hu B; Comas-Herrera A; King D; Rehill A; Shi C; Banerjee S; Patel A; Jagger C; Kingston A
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1095-1103. PubMed ID: 30950106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of depression among adults in Japan in 2005.
    Sado M; Yamauchi K; Kawakami N; Ono Y; Furukawa TA; Tsuchiya M; Tajima M; Kashima H; ; Nakane Y; Nakamura Y; Fukao A; Horiguchi I; Tachimori H; Iwata N; Uda H; Nakane H; Watanabe M; Oorui M; Funayama K; Naganuma Y; Hata Y; Kobayashi M; Ahiko T; Yamamoto Y; Takeshima T; Kikkawa T
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):442-50. PubMed ID: 21851453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.